ATE253040T1 - (2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-liganden - Google Patents

(2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-liganden

Info

Publication number
ATE253040T1
ATE253040T1 AT01906556T AT01906556T ATE253040T1 AT E253040 T1 ATE253040 T1 AT E253040T1 AT 01906556 T AT01906556 T AT 01906556T AT 01906556 T AT01906556 T AT 01906556T AT E253040 T1 ATE253040 T1 AT E253040T1
Authority
AT
Austria
Prior art keywords
aminoindanderivates
ligands
production
selective dopamine
dopamine
Prior art date
Application number
AT01906556T
Other languages
English (en)
Inventor
Thomas Andrew Runge
Arthur Glenn Romero
Bradley D Hewitt
Kjell A I Svensson
Chiu-Hong Lin
Kerry Anne Cleek
Susanne R Haadsma-Svensson
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ATE253040T1 publication Critical patent/ATE253040T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/48—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a six-membered aromatic ring being part of a condensed ring system of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Immunology (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT01906556T 2000-02-22 2001-02-14 (2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-liganden ATE253040T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18402000P 2000-02-22 2000-02-22
PCT/US2001/001231 WO2001062712A1 (en) 2000-02-22 2001-02-14 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands

Publications (1)

Publication Number Publication Date
ATE253040T1 true ATE253040T1 (de) 2003-11-15

Family

ID=22675272

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01906556T ATE253040T1 (de) 2000-02-22 2001-02-14 (2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-liganden

Country Status (13)

Country Link
US (2) US6410787B2 (de)
EP (1) EP1257527B1 (de)
JP (1) JP2003523991A (de)
AR (1) AR030552A1 (de)
AT (1) ATE253040T1 (de)
AU (1) AU2001234453A1 (de)
CO (1) CO5270005A1 (de)
DE (1) DE60101091T2 (de)
DK (1) DK1257527T3 (de)
ES (1) ES2210128T3 (de)
PT (1) PT1257527E (de)
TR (1) TR200302026T4 (de)
WO (1) WO2001062712A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461388B2 (en) * 2007-12-24 2013-06-11 Cipla Limited Process for the synthesis of propargylated aminoindan derivatives
JP5295613B2 (ja) * 2008-04-07 2013-09-18 日宝化学株式会社 ヨウ素化芳香族化合物の製造方法
CN102584801B (zh) * 2011-01-06 2015-02-18 中国科学院上海有机化学研究所 Hiv逆转录酶抑制剂依法韦伦类化合物的一锅法不对称合成工艺
CN104418775B (zh) * 2013-09-05 2017-01-18 中国科学院大连化学物理研究所 一种钯催化氨基醇的不对称氢解合成手性胺的方法
CN107056630B (zh) * 2017-01-23 2020-01-17 合肥工业大学 一种茚满类衍生物及其合成方法和在医药上的用途
CN113401961B (zh) * 2021-05-20 2023-06-23 陈鹏 一种可光谱调控的水处理用黑色素材料及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU7513494A (en) * 1993-08-06 1995-02-28 Upjohn Company, The 2-aminoindans as selective dopamine d3 ligands
ATE247639T1 (de) 1996-05-31 2003-09-15 Upjohn Co Arylsubstituierte cyclische amine als selektive dopamin-d3-liganden

Also Published As

Publication number Publication date
US6870070B2 (en) 2005-03-22
PT1257527E (pt) 2004-03-31
JP2003523991A (ja) 2003-08-12
US6410787B2 (en) 2002-06-25
US20010044471A1 (en) 2001-11-22
ES2210128T3 (es) 2004-07-01
US20020151596A1 (en) 2002-10-17
CO5270005A1 (es) 2003-04-30
TR200302026T4 (tr) 2004-01-21
WO2001062712A1 (en) 2001-08-30
DE60101091T2 (de) 2004-07-29
DE60101091D1 (de) 2003-12-04
DK1257527T3 (da) 2004-01-12
AU2001234453A1 (en) 2001-09-03
AR030552A1 (es) 2003-08-27
EP1257527B1 (de) 2003-10-29
EP1257527A1 (de) 2002-11-20

Similar Documents

Publication Publication Date Title
ATE347890T1 (de) Diarylcycloalkylderivate, verfahren zu ihrer herstellung und ihre verwendung als ppar- aktivatoren
DE502004011957D1 (de) Neue cyanopyrrolidide, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE355277T1 (de) Chinolin- und isochinolin-derivate, ein verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE60004382D1 (de) Zeolithische adsorbentien,verfahren zu ihrer herstellung und ihre verwendung zum entfernen von co2 aus gasströmen
DE502005009723D1 (de) Arylsubstituierte heterozyklen, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE50312261D1 (de) Heterozyklisch substituierte benzoylharnstoffe, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE10393704D2 (de) Nancomposite, Verfahren zu ihrer Herstellung und ihre Verwendung
ATE422154T1 (de) Im mund zerfallende tabletten und verfahren zu ihrer herstellung.
DE60233058D1 (de) Silsesquioxanderivate und verfahren zu ihrer herstellung
DE50102147D1 (de) Acylphenylharnstoffderivate, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE348609T1 (de) Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
DE50207011D1 (de) Arylisoxazolin-derivative, verfahren zu ihrer herstellung und ihre verwendung als schädlingsbekämpfungsmittel
ATE272634T1 (de) Benzothiophenderivate, verhahren zu ihrer herstellung und ihre verwendung
DE50110902D1 (de) Farb- und/oder effektgebende mehrschichtlackierung, verfahren zu ihrer herstellung und ihre verwendung
ATE473738T1 (de) 1-sulfonylindolderivate, verfahren zu ihrer herstellung und ihre verwendung als 5-ht6 liganden
DE50213372D1 (de) Substituierte 4-phenyltetrahydroisochinoline, verfahren zu ihrer herstellung, ihre verwendung als medikament, sowie sie enthaltendes medikament
DE50011818D1 (de) Hochkratzfeste mehrschichtlackierung, verfahren zu ihrer herstellung und ihre verwendung
ATE210638T1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
ATE293623T1 (de) Perfluoralkylhaltige komplexe mit zuckerresten, verfahren zu deren herstellung und ihre verwendung
ATE283842T1 (de) Substituierte benzoylketone, verfahren zu ihrer herstellung und ihre verwendung als herbizide
DE59912402D1 (de) Polycyclische thiazolidin-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE253040T1 (de) (2s)-aminoindanderivate, ein verfahren zu ihrer herstellung und ihre verwendung als selektive dopamin-d3-liganden
ATE313556T1 (de) Memno-peptide, verfahren zu ihrer herstellung und ihre verwendung
ATE222584T1 (de) Biphenylsulfonylcyanamide, verfahren zu ihrer herstellung und ihre verwendung als medikament
DE69922378D1 (de) Oxidierte sulfurierte distamycinderivate, verfahren zu ihrer herstellung und ihre verwendung als antitumormittel

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1257527

Country of ref document: EP

REN Ceased due to non-payment of the annual fee